NCT02321280View on ClinicalTrials.gov

The Efficacy of Denosumab in Active Crohn's Disease

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

April 20, 2018

Study Completion Date

April 20, 2018

Conditions
Crohn Disease
Interventions
DRUG

Denosumab

Single dose subcutaneous administration

Trial Locations (1)

R3A 1R9

University of Manitoba, Winnipeg

All Listed Sponsors
collaborator

University of Toronto

OTHER

collaborator

McMaster University

OTHER

lead

University of Manitoba

OTHER

NCT02321280 - The Efficacy of Denosumab in Active Crohn's Disease | Biotech Hunter | Biotech Hunter